San Francisco, United States
Reveri, founded in 2020 and headquartered in the United States, is a burgeoning player in the Health Care and Health and Wellness sectors, with adjacent interests in Sports. Its innovative mobile app offers users a chance to "Effortlessly relieve chronic pain and other conditions within minutes, with no medication or side effects."
The app is grounded in over 45+ years of clinical research and emphasizes self-hypnosis, a technique validated by science. This solution is gaining traction among over 50 thousand individuals seeking alternative pain management methods. Co-founder Dr. David Spiegel, esteemed for his work as Associate Chair of Psychiatry at Stanford, brings credibility and depth of expertise, having utilized hypnotherapy successfully to treat various conditions.
Reveri secured a $3.80M Seed Round investment on 09 February 2022 from investors including TheVentureCity, Background Capital, InReach Ventures, and notable angels like Eduardo Vilar, Bobby Lo, and Joe Greenstein. Its innovative approach is also spotlighted by major influencers on popular platforms.
